Citation: A. Argiris et al., High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease, ANN ONCOL, 11(6), 2000, pp. 665-672
Authors:
Marshall, NA
Howe, JG
Formica, R
Krause, D
Wagner, JE
Berliner, N
Crouch, J
Pilip, I
Cooper, D
Blazar, BR
Seropian, S
Pamer, EG
Citation: Na. Marshall et al., Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation, BLOOD, 96(8), 2000, pp. 2714-2721
Authors:
Marshall, NA
Howe, JG
Formica, R
Krause, D
Wagner, JE
Berliner, N
Crouch, J
Pilip, I
Cooper, D
Blazar, BR
Seropian, S
Pamer, EG
Citation: Na. Marshall et al., Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation, BLOOD, 96(8), 2000, pp. 2814-2821
Authors:
McGuirk, JP
Seropian, S
Howe, G
Smith, B
Stoddart, L
Cooper, DL
Citation: Jp. Mcguirk et al., Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing relatedhaplo-identical stem cell transplantation, BONE MAR TR, 24(11), 1999, pp. 1253-1258
Authors:
Seropian, S
Nadkarni, R
Jillella, AP
Salloum, E
Burtness, B
Hu, GL
Zelterman, D
Cooper, DL
Citation: S. Seropian et al., Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral bloodprogenitor cell transplant: out-patient treatment is a viable option, BONE MAR TR, 23(6), 1999, pp. 599-605